Search

Melissa Neal Phones & Addresses

  • Villa Park, IL
  • Chicago, IL
  • Carbondale, IL
  • Niles, IL
  • Denver, CO
  • 1562 S Owens St APT 262, Denver, CO 80232

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: High school graduate or higher

Professional Records

Medicine Doctors

Melissa Neal Photo 1

Melissa A. Neal

View page
Specialties:
Surgery , Neurological
Work:
Precision Spine Care
1814 Roseland Blvd STE 200, Tyler, TX 75701
(903) 595-8077 (phone), (903) 593-2224 (fax)
Languages:
English
Spanish
Description:
Ms. Neal works in Tyler, TX and specializes in Surgery , Neurological. Ms. Neal is affiliated with Mother Francis Hospital and Texas Spine & Joint Hospital.
Melissa Neal Photo 2

Melissa Ada Louise Neal

View page
Specialties:
Ophthalmology
Education:
Pennsylvania State University (1999)
University of Michigan Hospital (2003) *Ophthalmology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Melissa Neal
British School of Chicago LLC
Elementary/Secondary School
814 W Eastman St, Chicago, IL 60642
(773) 506-2097

Publications

Us Patents

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

View page
US Patent:
20210277056, Sep 9, 2021
Filed:
Jan 5, 2021
Appl. No.:
17/142169
Inventors:
- La Jolla CA, US
Kyle ATKINSON - Golden CO, US
Sandra BIROC - Alameda CA, US
Timothy BUSS - Carlsbad CA, US
Melissa NEAL - Vista CA, US
Vadim KRAYNOV - San Diego CA, US
Robin MARSDEN - San Diego CA, US
Jason PINKSTAFF - San Rafael CA, US
Lillian SKIDMORE - San Diego CA, US
Ying SUN - San Diego CA, US
Agnieszka SZYDLIK - San Francisco CA, US
Delia Ianina LOPEZ DE VALENTA - Poway CA, US
Assignee:
Ambrx, Inc. - La Jolla CA
International Classification:
C07K 5/103
C07D 207/08
C07D 401/12
C07D 417/12
C07K 5/02
A61K 47/68
A61K 38/07
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

View page
US Patent:
20180009845, Jan 11, 2018
Filed:
Sep 12, 2017
Appl. No.:
15/702682
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Marsden - San Diego CA, US
Jaosn Pinkstaff - San Rafael CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Agnieszka Szydlik - San Francisco CA, US
Delia Lanina Lopez De Valenta - Poway CA, US
Assignee:
Ambrx, Inc. - La Jolla CA
International Classification:
C07K 5/103
C07K 5/02
C07D 401/12
C07D 207/08
A61K 38/07
C07D 417/12
C07K 5/062
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

View page
US Patent:
20160052966, Feb 25, 2016
Filed:
May 24, 2012
Appl. No.:
14/122672
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Marsden - San Diego CA, US
Jason Pinkstaff - Encinitas CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Assignee:
AMBRX, INC. - La Jolla CA
International Classification:
C07K 5/103
A61K 47/48
A61K 38/07
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

View page
US Patent:
20150080559, Mar 19, 2015
Filed:
May 24, 2012
Appl. No.:
14/122667
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Mardsen - San Diego CA, US
Jason Pinkstaff - San Rafael CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Agnieszka Szydlik - San Francisco CA, US
Ianina Valenta - Poway CA, US
Assignee:
AMBRX, INC. - La Jolla CA
International Classification:
C07K 5/06
C07K 16/28
A61K 47/48
US Classification:
5303919, 548204, 548540, 5462791
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology uses.
Melissa K Neal from Villa Park, IL, age ~45 Get Report